NCT02611440

Brief Summary

Medication adherence is a major factor to prevent vascular recurrence after a first ischemic stroke. Nevertheless, it is suboptimal and the implementation of specific interventions are needed to improve it. A patient - centered and pluriprofessional structured intervention, targeting the medication, introduced at hospital discharge and continued at home (by regular telephone contact) could improve medication adherence one year after stroke. This intervention would consist of semi structured interviews patient-pharmacist at different times during one year after stroke. The information about the therapeutic management of the patient will be shared between healthcare professionals : general practitioners (GP) and community pharmacists (CP), hospital clinical pharmacist (HCP) and physician (HPhys). It will allow for decrease of the recurrent stroke and others cardiovascular complications based on a better adherence to preventive medication. Furthermore the decrease of the iatrogenic events and the improvement of the quality of life of patients may be also associated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 29, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2020

Completed
Last Updated

December 20, 2019

Status Verified

December 1, 2019

Enrollment Period

5 years

First QC Date

October 1, 2015

Last Update Submit

December 18, 2019

Conditions

Keywords

ischemic strokemedication adherencecardiovascular disease prevention

Outcome Measures

Primary Outcomes (1)

  • Measure of patient's adherence to medication. This adherence measurement is a composite measure

    A patient will be considered adherent if: 1. For each secondary-preventive drug (antiplatelet, lipid lowering, and antihypertensive), evaluated by the pharmacy refills: Number of days of medication available to the patient (supplied by the pharmacy divided by the total number of days in the period of the study (365)), is higher than 80%. 2. And score obtained from self-reported adherence questionnaire, greater than 6/8 is obtained for all secondary preventative medication

    One year after inclusion

Secondary Outcomes (11)

  • Analysis of pharmacy refills

    1 year after inclusion

  • Percentage of patients with drug-related iatrogenic events

    1 year after inclusion

  • Percentage of patients with a new stroke or cardiovascular event

    1 year after inclusion

  • Percentage of patients readmitted in hospitalization

    1 year after the inclusion

  • Realization of a questionnaire (Likert-type scale)

    1 year after inclusion

  • +6 more secondary outcomes

Study Arms (2)

Pharmacist Intervention

EXPERIMENTAL

It will be a semi -structured interviews with patient and pharmacist over various time after the stroke (at Month0, M3, M6, M9) combined with patient's therapeutic follow-up from various healthcare professionals.

Behavioral: Pharmaceutical care

Control

NO INTERVENTION

No pharmacist intervention planned.

Interventions

Initial interview with pharmacist (at the hospital discharge): Evaluation aimed to identify barriers to adherence to drug treatment followed by an information session on the disease, the benefit of drugs and the importance of diet and lifestyle habits. Pharmacist advices focused on how to take medication and how to manage adverse events will be provided. Telephone interviews with hospital clinical pharmacist - patient (at M3 M6 and M9): The objective is to review with the patient its medication-taking routine and its potential difficulties, to motivate adherence to treatment and lifestyle/dietary rules, to give advices about therapeutics and how to take medication. HCP contacts CP to determine the prescription refill. Final interview with HCP pharmacist (at M12): The objective is to take stock with the patient about its taking drug load.

Pharmacist Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged ≥ 18 years
  • Patient with ischemic stroke hospitalized in physical medicine and rehabilitation unit or neurovascular unit
  • Return at home at the hospital discharge
  • Medication including an antiplatelet drug or an oral anticoagulant with at least an antihypertensive drug and/or a lipid lowering agent (statin)
  • Patient without either cognitive disorders or major psychiatric disorders
  • Patient with a sufficient autonomy for the management of medication at home (score of Barthel \> 30)

You may not qualify if:

  • Patient ≤ 18 years
  • Patient with important cognitive or psychiatric disorders
  • Management of patient medication exclusively by the helper
  • No usual pharmacy (or more than 2 usual pharmacies)
  • Patient directed to an institution at the end of the hospitalization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Service de neurologie vasculaire, Hôpital P Wertheimer, HCL

Bron, 69677, France

RECRUITING

Service de médecine physique et de réadaptation, Hôpital Nord, CHU de Clermont Ferrand

Cébazat, 63 118, France

RECRUITING

Service de médecine physique et de réadaptation, Hôpital sud, CHU de Grenoble

Échirolles, 38434, France

RECRUITING

Service de médecine physique et de réadaptation, Groupe hospitalier Lariboisière - Fernand Vidal, AP-HP

Paris, 75010, France

RECRUITING

Service de médecine physique et de réadaptation, Hôpital Bellevue, CHU Saint Etienne

Saint-Etienne, 42055, France

NOT YET RECRUITING

Service de médecine physique et de réadaptation, Hôpital Henry Gabrielle, Groupement Hospitalier Sud, HCL

Saint-Genis-Laval, 69230, France

RECRUITING

Related Publications (1)

  • Khettar S, Jacquin Courtois S, Luaute J, Decullier E, Bin S, Dupuis M, Derex L, Mechtouff L, Nighoghossian N, Dussart C, Rode G, Janoly-Dumenil A. Multiprofessional intervention to improve adherence to medication in stroke patients: a study protocol for a randomised controlled trial (ADMED AVC study). Eur J Hosp Pharm. 2022 May;29(3):169-175. doi: 10.1136/ejhpharm-2020-002425. Epub 2020 Sep 25.

MeSH Terms

Conditions

Ischemic StrokeMedication Adherence

Interventions

Pharmaceutical Services

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPatient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Health ServicesHealth Care Facilities Workforce and Services

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2015

First Posted

November 20, 2015

Study Start

July 29, 2015

Primary Completion

July 28, 2020

Study Completion

July 28, 2020

Last Updated

December 20, 2019

Record last verified: 2019-12

Locations